Growers of human heart cells, Canadian-backed biotech firm Novoheart prepares for IPO

Run by Prof. Ronald Li, director of the Ming-Wai Lau Centre for Reparative Medicine at the Karolinska Institute’s Hong Kong campus, the company grows human heart tissue from stem cells that can be used instead of lab animals for drug development.
( read original story …)